Rentschler Biotechnologie, a German contract manufacturing organisation for the development and production of biopharmaceuticals, has appointed Frank Ternes to the position of Chief Business Officer. Ternes will lead the planning, development and execution of all business development, sales and marketing and project management activities.
Ternes brings more than 25 years of experience from operations and technology at Boehringer Ingelheim where he last served as Senior Vice President of Biopharmaceutical Contract Manufacturing.
